Restructuring Pharmaceutical Global Supply Chains after COVID-19

Raghbendra Jha; Ashok Sharma

Restructuring Pharmaceutical Global Supply Chains after COVID-19

Raghbendra Jha, Ashok Sharma

Research output: Contribution to Newspaper/Magazine/Bulletin › Article

Abstract

The COVID-19 outbreak provides India’s pharmaceutical industry a big opportunity, but responsibility as well. India is poised to be a key destination for manufacturing alternatives as the world looks to diversify the global supply chain away from China.

Original language	English
Pages	1-3
Number of pages	3
Specialist publication	Australian Journal of International Affairs
Publisher	Australian Institute of International Affairs
Publication status	Published - 21 May 2020

Access to Document

http://www.internationalaffairs.org.au/australianoutlook/reconstructing-pharmaceutical-global-supply-chains-after-covid-19/

Cite this

@misc{7533a34f1d734cdb941bd4677ca7362e,

title = "Restructuring Pharmaceutical Global Supply Chains after COVID-19",

abstract = "The COVID-19 outbreak provides India{\textquoteright}s pharmaceutical industry a big opportunity, but responsibility as well. India is poised to be a key destination for manufacturing alternatives as the world looks to diversify the global supply chain away from China.",

author = "Raghbendra Jha and Ashok Sharma",

year = "2020",

month = may,

day = "21",

language = "English",

pages = "1--3",

journal = "Australian Journal of International Affairs",

issn = "1465-332X",

publisher = "Australian Institute of International Affairs",

}

TY - GEN

T1 - Restructuring Pharmaceutical Global Supply Chains after COVID-19

AU - Jha, Raghbendra

AU - Sharma, Ashok

PY - 2020/5/21

Y1 - 2020/5/21

N2 - The COVID-19 outbreak provides India’s pharmaceutical industry a big opportunity, but responsibility as well. India is poised to be a key destination for manufacturing alternatives as the world looks to diversify the global supply chain away from China.

AB - The COVID-19 outbreak provides India’s pharmaceutical industry a big opportunity, but responsibility as well. India is poised to be a key destination for manufacturing alternatives as the world looks to diversify the global supply chain away from China.

M3 - Article

SN - 1465-332X

SP - 1

EP - 3

JO - Australian Journal of International Affairs

JF - Australian Journal of International Affairs

PB - Australian Institute of International Affairs

ER -

Restructuring Pharmaceutical Global Supply Chains after COVID-19

Abstract

Access to Document

Fingerprint

Cite this